Wordt geladen...
CD34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma
We report results of a retrospective analysis of 44 patients with relapsed and high-risk multiple myeloma (MM) undergoing allogeneic CD34-selected hematopoietic stem-cell transplantation (CD34-selected HSCT) from human leukocyte antigen (HLA)-compatible donors. Patients had multiply relapsed disease...
Bewaard in:
| Gepubliceerd in: | Biol Blood Marrow Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975432/ https://ncbi.nlm.nih.gov/pubmed/26325439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.025 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|